PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 3, 2026Clinical Medicine Insights Arthritis and Musculoskeletal Disorders0 citationsOpen Access

Interleukin-6 as a Marker of Joint Damage in Osteoarthritis: A Study of Its Pro-inflammatory Impacts

View Full Paper
DEDwitya ElviraDJDela Hangri Jalmas

Key Points

  • The study aims to explore how interleukin-6 levels relate to joint damage in knee osteoarthritis.
  • Included 46 patients with clinically diagnosed knee osteoarthritis
  • Measured joint space narrowing using radiographic examinations
  • Quantified IL-6 serum levels via enzyme-linked immunosorbent assay
  • Performed statistical analysis to assess the correlation between IL-6 and joint space narrowing
  • Average IL-6 level found to be 117.61 ng/mL
  • Average joint space narrowing measured at 1.76 mm
  • Found an inverse correlation between IL-6 levels and joint space narrowing (r = −0.298; P = 0.044)

Abstract

Background: Osteoarthritis (OA) is a degenerative joint disease characterized by a complex pathophysiology involving inflammatory biomarkers. Objectives: The current study aimed to investigate the correlation between interleukin-6 (IL-6) serum levels and joint space narrowing (JSN) in patients with knee OA. Design: A total of 46 patients clinically diagnosed with knee OA were included in this study. Methods: Joint space narrowing was measured using radiographic examinations, whereas blood serum levels of IL-6 were quantified using enzyme-linked immunosorbent assay. Statistical analysis was performed to determine the relationship between IL-6 and JSN. Results: The average level of IL-6 was 117.61 (67.05) ng/mL, with JSN measurement of 1.76 (1.31) mm. An inverse correlation found between IL-6 levels and the size of the gap joints in patients with knee OA ( r = −.298; P = .044). Conclusion: An inverse correlation exists between IL-6 levels and joint impairment in knee OA, suggesting that inflammation plays a crucial role in the progression of the disease.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Elvira et al. (2026) studied this question.

synapsesocial.com/papers/69cf5ecb5a333a821460d62fhttps://doi.org/10.1177/11795441261436818
Ask AI
Helpful
Bookmark
Share
View Full Paper